Literature DB >> 9177245

Agonist-induced closure of constitutively open gamma-aminobutyric acid channels with mutated M2 domains.

Z H Pan1, D Zhang, X Zhang, S A Lipton.   

Abstract

Ligand-gated ion channels display a fundamental property-channels remain virtually closed at rest and open upon agonist binding. Here we show that substituting alanines for either of two amino acid residues (T314 or L317) in the M2 region of the gamma-aminobutyric acid (GABA) rho1 subunit results in spontaneous channel opening in the absence of ligand. Surprisingly, for two single point mutants (T314A or L317A), application of very low concentrations of agonist partially suppressed this spontaneous current, while higher concentrations re-activated the receptors. When both of these sites were mutated (T314A/L317A), GABA nearly completely suppressed the constitutive current and did not re-activate the current even at very high concentrations. This study provides important new insights into the structure-function relationship of ligand-gated ion channels, where modification of the structure of the channel pore region not only alters the allosteric transition of the receptor protein but also reverses the polarity of agonist regulation of channel gating. Our results suggest that the sites where these two residues are located are structurally critical for channel gating.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9177245      PMCID: PMC21077          DOI: 10.1073/pnas.94.12.6490

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  The strychnine-binding subunit of the glycine receptor shows homology with nicotinic acetylcholine receptors.

Authors:  G Grenningloh; A Rienitz; B Schmitt; C Methfessel; M Zensen; K Beyreuther; E D Gundelfinger; H Betz
Journal:  Nature       Date:  1987 Jul 16-22       Impact factor: 49.962

2.  Dependence of acetylcholine receptor channel kinetics on agonist concentration in cultured mouse muscle fibres.

Authors:  M B Jackson
Journal:  J Physiol       Date:  1988-03       Impact factor: 5.182

3.  Evidence that the M2 membrane-spanning region lines the ion channel pore of the nicotinic receptor.

Authors:  R J Leonard; C G Labarca; P Charnet; N Davidson; H A Lester
Journal:  Science       Date:  1988-12-16       Impact factor: 47.728

4.  The role of conserved leucines in the M2 domain of the acetylcholine receptor in channel gating.

Authors:  G N Filatov; M M White
Journal:  Mol Pharmacol       Date:  1995-09       Impact factor: 4.436

5.  Cloning of a putative gamma-aminobutyric acid (GABA) receptor subunit rho 3 cDNA.

Authors:  T Ogurusu; R Shingai
Journal:  Biochim Biophys Acta       Date:  1996-02-07

6.  Acetylcholine receptor channel imaged in the open state.

Authors:  N Unwin
Journal:  Nature       Date:  1995-01-05       Impact factor: 49.962

7.  Amino acids lining the channel of the gamma-aminobutyric acid type A receptor identified by cysteine substitution.

Authors:  M Xu; M H Akabas
Journal:  J Biol Chem       Date:  1993-10-15       Impact factor: 5.157

8.  Gamma-aminobutyric acid binding to receptor sites in the rat central nervous system.

Authors:  S R Zukin; A B Young; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1974-12       Impact factor: 11.205

9.  Pharmacology of GABA receptor Cl- channels in rat retinal bipolar cells.

Authors:  A Feigenspan; H Wässle; J Bormann
Journal:  Nature       Date:  1993-01-14       Impact factor: 49.962

10.  Equilibrium binding of [3H]tubocurarine and [3H]acetylcholine by Torpedo postsynaptic membranes: stoichiometry and ligand interactions.

Authors:  R R Neubig; J B Cohen
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more
  13 in total

1.  Allosteric activation mechanism of the alpha 1 beta 2 gamma 2 gamma-aminobutyric acid type A receptor revealed by mutation of the conserved M2 leucine.

Authors:  Y Chang; D S Weiss
Journal:  Biophys J       Date:  1999-11       Impact factor: 4.033

Review 2.  Allosteric activation mechanism of the cys-loop receptors.

Authors:  Yong-chang Chang; Wen Wu; Jian-liang Zhang; Yao Huang
Journal:  Acta Pharmacol Sin       Date:  2009-05-11       Impact factor: 6.150

3.  An engineered glutamate-gated chloride (GluCl) channel for sensitive, consistent neuronal silencing by ivermectin.

Authors:  Shawnalea J Frazier; Bruce N Cohen; Henry A Lester
Journal:  J Biol Chem       Date:  2013-05-29       Impact factor: 5.157

4.  Mutation at the putative GABA(A) ion-channel gate reveals changes in allosteric modulation.

Authors:  S A Thompson; M Z Smith; P B Wingrove; P J Whiting; K A Wafford
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

5.  Evidence for a centrally located gate in the pore of a serotonin-gated ion channel.

Authors:  Sandip Panicker; Hans Cruz; Christine Arrabit; Paul A Slesinger
Journal:  J Neurosci       Date:  2002-03-01       Impact factor: 6.167

6.  Molecular determinants of ivermectin sensitivity at the glycine receptor chloride channel.

Authors:  Timothy Lynagh; Timothy I Webb; Christine L Dixon; Brett A Cromer; Joseph W Lynch
Journal:  J Biol Chem       Date:  2011-10-27       Impact factor: 5.157

7.  Permeability and single channel conductance of human homomeric rho1 GABAC receptors.

Authors:  V E Wotring; Y Chang; D S Weiss
Journal:  J Physiol       Date:  1999-12-01       Impact factor: 5.182

8.  Modulation of the human ρ1 GABAA receptor by inhibitory steroids.

Authors:  Megan M Eaton; You Bin Lim; Douglas F Covey; Gustav Akk
Journal:  Psychopharmacology (Berl)       Date:  2013-12-07       Impact factor: 4.530

9.  Identification of an Inhibitory Alcohol Binding Site in GABAA ρ1 Receptors.

Authors:  Cecilia M Borghese; Carlos I Ruiz; Ui S Lee; Madeline A Cullins; Edward J Bertaccini; James R Trudell; R Adron Harris
Journal:  ACS Chem Neurosci       Date:  2015-11-25       Impact factor: 4.418

10.  Studies on the mechanisms of action of picrotoxin, quercetin and pregnanolone at the GABA rho 1 receptor.

Authors:  Juan D Goutman; Daniel J Calvo
Journal:  Br J Pharmacol       Date:  2004-01-19       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.